Skip to main content

Table 2 Effect of glycerol supplementation and L. reuteri PTA5_F13 on the metabolic activity of chicken cecal microbiota during in vitro F2

From: Glycerol and reuterin-producing Limosilactobacillus reuteri enhance butyrate production and inhibit Enterobacteriaceae in broiler chicken cecal microbiota PolyFermS model

Reactors

Mean metabolite concentration (mM) ± SD

Ratios of Total SCFAs (%)

Acetate

Butyrate

Propionate

Succinate

Valerate

1,3 – PDO

Total BCFAs

Total metabolites

Acetate

Butyrate

Propionate

CR

 Pre-treatment

91.2 ± 0.9

28.8 ± 0.1

23.1 ± 1.0

7.1 ± 0.8

8.3 ± 0.1

0.0 ± 0.0

14.8 ± 0.2

174.1 ± 1.9

63.7 ± 0.7

20.1 ± 0.1

16.2 ± 0.7

 Treatment

95.9 ± 1.0

27.2 ± 0.6

21.9 ± 0.3

6.8 ± 0.2

7.1 ± 0.1

0.0 ± 0.0

14.9 ± 0.2

174.0 ± 1.3

66.1 ± 0.2

15.1 ± 0.2

18.8 ± 0.4

 Treatment – Pre treatment

 + 4.7

- 1.6

- 2.1

- 0.3

- 1.2

-

 + 0.1

- 0.1

 + 2.4

- 5.0

 + 2.6

 P value

0.0036

0.0118

0.1220

0.6486

0.0002

 

0.7179

0.9254

0.0059

0.0041

0.0606

100G

 Pre-treatment

96.2 ± 2.6

39.8 ± 0.9

14.0 ± 0.7

4.2 ± 0.4

5.7 ± 0.9

0.0 ± 0.0

13.7 ± 0.2

174.0 ± 1.9

64.1 ± 0.8

26.5 ± 0.5

9.3 ± 0.6

 Treatment

61.4 ± 1.7

63.3 ± 0.7

14.7 ± 1.1

3.6 ± 0.2

4.8 ± 0.3

23.0 ± 1.2

12.1 ± 0.2

183.4 ± 1.8

44.0 ± 0.6

45.4 ± 0.9

10.6 ± 0.7

 Treatment – Pre treatment

- 34.8

 + 23.5

 + 0.7

- 0.6

- 0.9

 + 23.0

- 1.6

 + 9.4

- 20.1

 + 18.9

 + 1.3

 P value

0.000039

0.000004

0.3918

0.0602

0.1644

0.000006

0.0004

0.0036

0.000004

0.000006

0.0915

Lbr

 Pre-treatment

91.4 ± 1.5

32.9 ± 0.3

19.9 ± 0.5

5.9 ± 0.4

8.0 ± 0.2

0.0 ± 0.0

15.4 ± 0.3

173.6 ± 2.3

63.4 ± 0.3

22.8 ± 0.1

13.7 ± 0.3

 Treatment

92.4 ± 1.9

36.1 ± 1.2

17.0 ± 0.3

4.0 ± 0.3

6.9 ± 0.7

0.0 ± 0.0

15.0 ± 0.6

171.5 ± 2.7

63.5 ± 0.7

24.7 ± 0.6

11.6 ± 0.4

 Treatment – Pre treatment

 + 1.0

 + 3.2

- 2.9

- 1.9

- 1.1

-

- 0.4

- 2.1

 + 0.1

 + 1.9

- 2.1

 P value

0.3524

0.0121

0.0007

0.0017

0.0582

 

0.4322

0.7846

0.7857

0.0065

0.0019

Lbr-100G

 Pre-treatment

89.6 ± 2.1

30.3 ± 0.9

27.1 ± 0.6

4.3 ± 0.5

5.4 ± 1.9

0.0 ± 0.0

14.9 ± 0.3

171.7 ± 3.1

60.9 ± 0.9

20.6 ± 0.6

18.5 ± 0.5

 Treatment

74.0 ± 2.4

51.6 ± 0.2

22.8 ± 0.3

7.7 ± 0.6

10.4 ± 0.3

20.4 ± 0.3

13.2 ± 0.3

199.7 ± 3.1

49.9 ± 0.7

34.7 ± 0.6

15.4 ± 0.1

 Treatment – Pre treatment

- 15.6

 + 21.3

- 4.3

 + 3.4

 + 5

 + 20.4

- 1.7

 + 28.0

- 11.0

 + 14.1

- 3.1

 P value

0.0011

0.000003

0.0004

0.0017

0.0152

 < 0.000001

0.0022

0.0003

0.000085

0.000007

0.0004

  1. Data are means ± SD for the last 3 days of each treatment period. Delta corresponds the difference between treatment and pre-treatment. P value is calculated for the pairwise comparison of the last 3 days of treatment and pre-treatment periods within a reactor by unpaired t-test. CR, Control reactor; 100G, 100 mM glycerol; Lbr, L. reuteri PTA5_F13; Lbr-100G, L. reuteri PTA5_F13 and 100 mM glycerol